SCHEDULE 13G: Capital World Investors Discloses 5.5% Stake in CVS Health Corp.

Capital World Investors has filed a Schedule 13G, revealing a beneficial ownership of 5.5% of CVS Health Corp.'s common stock as of March 31, 2025.

Summary

• Capital World Investors, a division of Capital Research and Management Company, has filed a Schedule 13G with the SEC.
• The filing indicates that Capital World Investors beneficially owns 68,785,990 shares of CVS Health Corp. common stock.
• This ownership represents 5.5% of the total outstanding shares of CVS Health Corp., based on 1,260,795,063 shares believed to be outstanding.
• Capital World Investors holds sole voting power over 68,208,572 shares and sole dispositive power over 68,785,990 shares.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of CVS Health Corp.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing reflects a significant passive investment by a major institutional asset manager in a leading U.S. healthcare company. It does not provide specific insights into CVS Health Corp.'s operational performance or strategic direction, but rather discloses an existing ownership stake by a large investment firm.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can be viewed as a vote of confidence by a major investor.
• Market: The disclosure of a substantial stake by a prominent investment firm may influence market perception and trading activity for CVS Health Corp. shares.

Key Dates

Keywords

CVS Health Corp., Capital World Investors, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser, Healthcare, Pharmacy